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Abstract
Introduction In critically ill patients, delirium is a serious and
frequent disorder that is associated with a prolonged intensive
care and hospital stay and an increased morbidity and mortality.
Without the use of a delirium screening instrument, delirium is
often missed by ICU nurses and physicians. The effects of
implementation of a screening method on haloperidol use is not
known. The purpose of this study was to evaluate the
implementation of the confusion assessment method-ICU
(CAM-ICU) and the effect of its use on frequency and duration
of haloperidol use.
Methods We used a tailored implementation strategy focused
on potential barriers. We measured CAM-ICU compliance,
interrater reliability, and delirium knowledge, and compared the
haloperidol use, as a proxy for delirium incidence, before and
after the implementation of the CAM-ICU.
Results Compliance and delirium knowledge increased from
77% to 92% and from 6.2 to 7.4, respectively (both, P <
0.0001). The interrater reliability increased from 0.78 to 0.89.
More patients were treated with haloperidol (9.9% to 14.8%, P
< 0.001), however with a lower dose (18 to 6 mg, P = 0.01) and
for a shorter time period (5 [IQR:2–9] to 3 [IQR:1–5] days, P =
0.02).
Conclusions With a tailored implementation strategy, a delirium
assessment tool was successfully introduced in the ICU with the
main goals achieved within four months. Early detection of
delirium in critically ill patients increases the number of patients
that receive treatment with haloperidol, however with a lower
dose and for a shorter time period.
Introduction
Delirium is a common psychiatric disorder in critically ill
patients. It has an acute onset and combines cognitive and
attention defects with a fluctuating consciousness [1]. It is
associated with a prolonged intensive care and hospital stay
and an increased morbidity and mortality [2-4].
Although there has been increasing interest in delirium in the
past five years, standard screening of patients in daily practice
is still not common, resulting in an underestimation of the prob-
lem. Previous studies showed that, without the use of a
screening instrument, more than 60% of patients with delirium
are missed by ICU nurses and more than 70% by physicians
[5,6]. It can therefore be assumed that delirious patients are
not sufficiently treated if they are not recognized. The inci-
dence rate in critically ill patients varies between 11% and
87%, depending on the study design, methods for assess-
ment, and differences in population [2,4,7-9].
Although there is no evidence that the use of a delirium
assessment tool results in improvement of outcome, early rec-
ognition of delirium is important for adequate and early treat-Page 1 of 7
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addition, because of the fluctuating clinical signs and symp-
toms of delirium, screening should be performed at least once
every 8 to 12 hours [10,11]. A delirium assessment tool
should therefore be quick and easy to use with a high interrater
reliability.
The Dutch guidelines Delirium in the Intensive Care recom-
mends the screening of all ICU patients with a reliable and val-
idated delirium screening instrument (van Eijk MJJ, Spronk PE,
van den Boogaard MHWA, Kuiper MA, Smit EGM, Slooter
AJC. Delirium op de Intensive Care, unpublished data), such
as the intensive care delirium screening checklist (ICDSC)
[12] or the confusion assessment method-ICU (CAM-ICU)
[13].
The treatment of delirium is based on removing the underlying
somatic disorder frequently combined with pharmacological
therapy. Although there is no clear evidence that treatment
improves the prognosis of delirious ICU patients [14], and
haloperidol has significant side effects [15,16], haloperidol is
the most commonly recommended pharmacological agent
[17]. As screening will probably increase the number of
patients diagnosed with delirium, it could also increase the use
of haloperidol. In view of this, it is important to determine the
effect of the implementation of a screening instrument on the
use of haloperidol.
The first aim of our study was to evaluate our strategy for the
implementation of the CAM-ICU. Therefore, the compliance
with scoring of the CAM-ICU, the interrater reliability, and
improvement in delirium knowledge of the nurses were used
as indicators for successful implementation. We assumed that
a larger number of delirious patients would be detected with
the use of the CAM-ICU, in comparison with previous periods
without the standard use of a screening tool. The second aim
of our study was therefore to assess how the CAM-ICU influ-
ences the frequency and duration of haloperidol use, which
may be considered to be a proxy for the delirium incidence and
duration.
Materials and methods
This study was conducted in the Radboud University
Nijmegen Medical Centre, the Netherlands, a 960-bed univer-
sity hospital that includes a level 3 (highest level) ICU with 40
beds divided over four adult wards and one paediatric ward.
Annually 2000 to 2500 (cardiothoracic surgery, neurosurgical,
medical, surgical, and trauma) patients are admitted.
The local Institutional Review Board of Arnhem-Nijmegen indi-
cated that for this study no approval was required and no
informed consent from patients was needed.
Nurses and the implementation of the CAM-ICU
Although the ICDSC and the CAM-ICU are suitable delirium
screening instruments, we preferred to implement the CAM-
ICU above the ICDSC because of the higher sensitivity and
specificity, and because the CAM-ICU is translated and vali-
dated in Dutch [18]. The CAM-ICU is an easy to perform
assessment tool for ICU nurses, which consists of a two-step
approach model [13] [see Additional data file 1]. Before the
implementation of the CAM-ICU, identification of delirious
patients was based on the judgement of the attending ICU
physician, and a delirium screening instrument was not used.
Due to the potential importance of unrecognised delirium, we
decided that this should be changed to a situation where reg-
ular and systematic assessment of delirium was performed by
ICU nurses with specific knowledge of delirium recognition.
Therefore, we introduced the CAM-ICU as an instrument for
early recognition of delirium and started with the implementa-
tion on all four adult ICU wards in December 2007.
Implementation of a delirium assessment tool in daily practice
introduces an essential change for ICU nurses. As there is no
single best method for implementing an innovation in all set-
tings [19], it is important to identify potential barriers and facil-
itators in this particular setting. For a good adaptation of a
delirium screening instrument it is important to tailor the imple-
mentation strategy to these facilitators and barriers [20]. Fur-
thermore, support from the organisation and medical and
nursing staff participation is important for a successful imple-
mentation [21].
Our implementation strategy [see Additional data file 2] was
focused on potential barriers and facilitators for screening with
the CAM-ICU (Table 1), which were identified during several,
unstructured, interviews with the nursing and medical staff.
We integrated the CAM-ICU algorithm in our patient data
management system, which is available at all bedside comput-
ers. Because of the fluctuating course of delirium every patient
had to be assessed minimally once in every eight-hour shift,
according to the CAM-ICU manual [22]. If the mental status
changed after an assessment, an additional assessment had
to be performed. Patients were excluded from screening when
they had a Richmond agitation sedation score of -4 or -5 [13],
were unable to understand Dutch, were severely mentally dis-
abled, or suffered from a serious receptive aphasia. All neces-
sary testing tools (attention screening pictures and
disorganized thinking questions) were made available at every
bed. The computer notified the nurse about the outcome of the
CAM-ICU screening, that is, delirious or not.
Evidence-based interventions [23] included in the implemen-
tation strategy were: education; educational outreach visits;
reminders and feedback; and leadership.Page 2 of 7
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All ICU nurses were trained in the use of the CAM-ICU and
performed a knowledge test prior to the training. The educa-
tion consisted of a one-hour group training prior to the imple-
mentation of the CAM-ICU. During this training, information
about delirium features, recognition, and delirium types was
given. Furthermore, specific information was given about the
CAM-ICU. We used educational material from the delirium
website [22] such as the training video and the Harvard CAM-
ICU flow sheet. We appointed 'delirium key-nurses', who
received supplementary training, for further instruction and
introduction of the CAM-ICU in their unit. In addition, posters
with the Harvard CAM-ICU flow sheet were distributed to
nurses and the medical staff. Also, the medical staff was
informed about delirium and the CAM-ICU. Supplementary
individual training on the job (by MvdB, and the 'delirium key-
nurses') started one month after the implementation and was
given whenever screening compliance and interrater reliability
dropped below the stated aim. The focus during this training
on the job was on the most common mismatches, that is fea-
ture 1A and 1B [see Additional data file 1]. Determination of
the presence of cognitive function disturbances and the fluc-
tuating nature of consciousness were the most difficult points
for the ICU nurses. Individual problems with the assessment
were addressed by focusing the training on the difficulties
experienced during observations.
Reminders and feedback
When a delirium assessment was not carried out, a pop-up
appeared on the bedside computer as a reminder for the
nurse. The CAM-ICU scoring rate, that is the screening com-
pliance, and the interrater reliability were measured. The
results were evaluated with the delirium key-nurses and the
nursing staff, twice a week as parameters of a successful
implementation. Feedback about results and performance of
the CAM-ICU was supplied weekly by e-mail and during
monthly clinical meetings.
Leadership
The medical and nursing staff committed themselves to, and
supported the implementation of the delirium assessment tool,
as agreed upon during the information meeting and was
reported during feedback of the key nurses. One project
leader was responsible and supervised the implementation
process (MvdB). Prior to the implementation, the CAM-ICU
was introduced to the medical staff. Two months after the
implementation, the presence of delirium became a standard
part of the daily multidisciplinary meeting, in which all patients
are discussed. All ICU wards were visited daily by the project
leader to identify problems concerning the performance and
compliance of the assessment tool and for personal or group
feedback.
Chosen indicators of a successful implementation were: regu-
lar assessment of all ICU patients defined as a screening com-
pliance of more than 80%; interrater reliability score of more
than 0.80; and improvement of the level of knowledge con-
cerning delirium.
The compliance was calculated as the percentage of per-
formed assessments per day of the total number of assess-
ments that should have been performed. Interrater reliability
tests were performed several times during the first month after
the implementation and twice a week during and after the
training on the job period. For this the CAM-ICU score
assessed by the ICU nurse was compared with the CAM-ICU
score assessed by an expert psychiatric nurse (GR). The max-
imum period between the two assessments was one hour and
patients were chosen randomly. Patients who were excluded
from screening with the CAM-ICU were also excluded from the
interrater reliability testing.
We developed a non-validated written delirium knowledge test
that had to be completed in 10 minutes prior to the delirium
training and consisted of 10 mixed open and closed ques-
tions. A similar post-training test was performed four months
later. 'Delirium knowledge' is expressed on a scale of 0 to 10.
The implementation period started in December 2007 and
ended in March 2008, after reaching the indicators of care
improvement (Figure 1). The nursing staff consists of 140
nurses of which 18 (13%) were ICU nurses in training.
The patients and haloperidol treatment
As delirium incidence rates before the use of the assessment
tool were not available, we used the frequency of haloperidol
use as a proxy for delirium incidence. Data of all patients who
were treated with haloperidol are available through our patient
data management system. As a general rule, in our ICU all
Table 1
Identified potential barriers and facilitators during interviews
Implementation barriers Implementation facilitators
1. Lack of knowledge concerning delirium 1. Patient data management system
2. Inavailability of the assessment tool 2. Senior nurses
3. To fill in the delirium assessment tool on paper three times a day ('paperwork') 3. Support of medical and nursing staff
4. Time to perform the assessment 4. Delirium researcherPage 3 of 7
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and delirium is the only reason for prescribing haloperidol. The
duration of haloperidol treatment was used as a proxy for the
duration of the delirious period. For the incidence rate of a
four-month period (March until June 2008) after the implemen-
tation, the CAM-ICU results were compared with the haloperi-
dol use during the same period of the two previous years. We
compared the total number of all consecutive patients treated
with haloperidol, total days of treatment, and the total dose of
administered haloperidol per patient and per day.
Statistical analyses
All data analyses were performed with SPSS 16.0 (SPSS Inc.,
Chicago, IL, USA). Normally distributed data (demographic
data, knowledge level, and the scorings rate) were tested par-
ametrically (Student's t-test, repeated measurement analysis
of variance). Data concerning the treatment with haloperidol
were not normally distributed and were tested non-parametri-
cally with the Friedman test and the Kruskal-Wallis one-way
analysis of variance test. Interrater reliability of the outcome of
screening, that is delirious or non-delirious, was calculated
with the Cohen's Kappa statistic.
Results
Evaluation of implementation and nurses
In the first month of the implementation period the interrater
reliability was 0.78 (n = 25, 95% confidence interval (CI): 0.5
to 1.0) and following intensive training on the job of almost all
ICU nurses this increased to 0.89 (n = 47, 95%CI: 0.75 to
1.0).
In the first month after the implementation the compliance of
screening with the CAM-ICU was 77% and increased signifi-
cantly to 92% (repeated measurement analysis of variance, P
< 0.0001) after four months. Scoring rate of the nurses at the
pre-course delirium knowledge test was 6.2 ± 1.7 (n = 136)
and increased significantly to 7.4 ± 1.2 (n = 122) four months
later (Student's t-test, P = 0.0001).
Haloperidol treatment and patients
With the exception of a small, but statistically significant differ-
ence in the Acute Physiology and Chronic Health Evaluation-II
(APACHE-II) score, the demographic variables of the patients
did not differ between the three years (Table 2). In the same
period in 2006 and 2007, 13 (10%) and 20 (13%) patients
per month were treated with haloperidol, respectively (Table
3). Following the implementation period, based on the CAM-
ICU results, this increased significantly to 37 (23%) patients
per month (P < 0.001) compared with the previous period
without the use of the CAM-ICU. All patients who received
haloperidol in the period after the implementation in 2008
were detected with the CAM-ICU as delirious patients. From
these 147 delirious patients, 25 (17%) had a hyperactive type,
47 (32%) a hypoactive type, and 74 patients (50.3%) had a
mixed-type delirium. During this period 641 patients were
admitted of which 74 patients were excluded from CAM-ICU
screening. The most frequent reason was sustained coma
(49%). To compare the effect on the detected incidence
before and after the implementation of the CAM-ICU, we used
the total of 641 patients, because of the lack of information of
the patients in the period before the implementation.
Figure 1
Implementation flow chart. CAM-ICU = confusion assessment method-intensive care unit.Page 4 of 7
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from five (interquartile range (IQR) 2 to 9) to three days (IQR
1 to 5) after the implementation of the CAM-ICU (P = 0.02).
The median total haloperidol dose per patient (during treat-
ment) decreased from 18 mg (IQR 5 to 39.5) to 6 mg (IQR 2
to 19.5; P = 0.01).
Discussion
In a relatively short period of four months, we successfully
implemented a validated delirium assessment tool in our daily
practice on the ICU. Following the implementation of the
CAM-ICU, more patients were treated with haloperidol, but
with a lower dose and for a shorter period of time when com-
pared with the same period in the two previous years. Almost
two times more delirious patients were detected with the use
of the CAM-ICU. Our results indicate that successful imple-
mentation of the CAM-ICU is possible and, importantly, that
this results in shorter and lower dosed haloperidol treatment.
The implementation of the CAM-ICU
We feel that several aspects of our implementation strategy
are responsible for this success. First, we used a multifaceted
model with evidence-based interventions. Although we did not
measure the effect of the separate interventions, previous
studies showed that education and feedback with reminders
are very effective interventions [23]. Second, it is important to
focus the implementation strategy on potential barriers that
can be expected in daily practice [19], which will differ from
hospital to hospital and from ward to ward. We therefore gath-
ered information about these potential barriers prior to the
actual implementation. Based on this information, we used the
facilitators of our organization and integrated the CAM-ICU in
our patient data management system. Although it took some
time to develop the integrated CAM-ICU, it was easier to use
and included a reminder when the assessment had not been
performed at the end of the shift. The key-nurses played an
important role in supporting the group and therefore were piv-
otal. They were also particularly helpful in bedside training of
the ICU nurses, their direct colleagues.
Table 2
Demographic variables of ICU-patients before and after implementation of CAM-ICU
Period Prior to implementation
March to June 2006
Prior to implementation
March to June 2007
After implementation March to June 
2008
P value
Number of patients 512 589 641
Age 57.5 ± 16.4 58.9 ± 16.6 59.5 ± 15.6 N.S.
Gender (M/F) 339/173 370/219 409/232 N.S.
APACHE-II score 16.9 ± 7.0 17.1 ± 6.9 15.5 ± 6.5 0.0001
Length of stay on ICU in days (median 
(IQR))
1.3 (0.8 to 5.9) 1.0 (1 to 5) 1.0 (1 to 3) N.S.
Admission type (n)
Elective surgery 214 (42%) 283 (48%) 340 (53%) N.S.
'Urgent surgery 106 (20%) 96 (16%) 76 (12%)
Medical 192 (38%) 210 (36%) 225 (35%)
All values are means ± standard deviation unless otherwise reported.
APACHE II = Acute Physiology and Chronic Health Evaluation II; CAM-ICU = confusion assessment method-intensive care unit; F = female; ICU 
= intensive care unit; IQR = interquartile range; M = male; N.S. = non-significant.
Table 3
Effect of the implementation of the CAM-ICU in 2008 on delirium treatment
2006
(n = 512)
2007
(n = 589)
2008
(n = 641)
P value
Total numbers of delirious patients (%) 51 (10%) 79 (13%) 147 (23%) < 0.0001
Number of delirious patients per month 13 20 37 < 0.0001
Total dose of haloperidol per patient (mg)
n = total number of patients treated with haloperidol
18 (5 to 40)
(n = 52)
12.5 (3 to 30)
(n = 80)
6 (2 to 20)
(n = 147)
0.01
Duration of treatment (days) 5 (2 to 9) 3 (2 to 9) 3 (1 to 5) 0.02
All values are medians (interquartile range) unless other reported. CAM-ICU = confusion assessment method-intensive care unit.Page 5 of 7
(page number not for citation purposes)
Critical Care    Vol 13 No 4    van den Boogaard et al.A final point of interest is the cooperation with the medical
staff. We noticed that it is important that the CAM-ICU score
is part of the daily evaluation of the patient and that it is also
important to react adequately to a positive delirious score by
treating the patient. Therefore, it is also important to inform the
medical staff during the implementation (education) and give
them regular feedback on the results of the implementation
(compliance, interrater reliability, and delirium knowledge
level). As these interventions are tailored to the barriers found
in this study they should not be used as a blueprint for imple-
mentation but could serve as a guideline.
Although the CAM-ICU appears to be relatively simple to use
and a relatively short training period should result in a reliable
performance of the CAM-ICU [11,13], our study demonstrates
that an intensive implementation strategy results in a further
improvement of its performance. We aimed for a group inter-
rater reliability score of at least 0.8, which can be considered
a desirable [24] and attainable goal for the CAM-ICU [13]. Evi-
dently, it is of utmost importance to test the reliability of the
assessment by the ICU nurses, because a false-positive diag-
nosis may result in unnecessary treatment and vice versa.
Therefore, in our view, it is necessary to perform interrater reli-
ability tests and analyse the mismatches to be able to give
adequate feedback. Unfortunately, and surprisingly, not much
attention is given to this aspect in the literature and many new
screening and treatment policies appear to be implemented
without it.
Although a high interrater reliability is important for the per-
formance of the CAM-ICU, a screening tool will only be effec-
tive when the compliance with its use is also high. Although we
did not formally measure the nursing workload, it is clear that
the screening of patients with the CAM-ICU results in some
additional work for the nurses. Our experience is that the mean
screening time of the patients with the CAM-ICU is two to five
minutes, which is comparable with that mentioned by Ely and
colleagues [13]. Based on a study by Soja and colleagues
[25] we chose an 80% compliance with the CAM-ICU as a
feasible and acceptable aim for a successful implementation.
Scoring all patients three times a day during their whole stay
on the ICU is hardly realistic. Moreover, an optimal compliance
is unknown. We are convinced that the intensive feedback and
support of the project leader and the medical and nursing staff
played an important role in achieving a high compliance.
Haloperidol treatment and patients
One could argue that haloperidol use is not a good proxy for
the incidence of delirium because it is also used to treat other
disorders such as serious psychoses, severe excitement, and
anxiety [26]. However, these disorders are rarely observed in
our ICU or not treated with haloperidol. In the case of agitation
in patients without a protected airway we use a low dose of
propofol, if necessary in combination with oxazepam. There-
fore we are confident that in our ICU only delirious patients are
treated with haloperidol and that the observed difference in
haloperidol use between the compared treatment periods can
only be attributed to differences in delirium detection rate.
Despite the fact that we found a higher incidence of delirious
patients with the CAM-ICU than without the use of a screening
instrument, the incidence in our population is low. A possible
explanation is that the study was performed in all consecutive
patients, with no selection of high-risk patient groups. Includ-
ing patients that were admitted to our ICU following elective
surgery may also partly explain why the APACHE II score is
lower compared with other studies that reported higher
APACHE II scores associated with a higher incidence of delir-
ium [13,27,28].
It is assumed that the regular use of a delirium assessment tool
results in a higher detection rate of delirious patients, espe-
cially patients with a hypoactive delirium. Naturally, this could
result in more haloperidol use. Given the potential side effects
of the drug, the absence of clear evidence that presence of
hypoactive delirium is associated with poor patient outcome
and that the use of a delirium assessment tool improves the
outcome of the ICU patient, one might argue that an increase
in haloperidol use is not desirable. On the other hand, an ear-
lier and improved recognition of delirious patients may make it
easier to treat the delirium with lower doses of haloperidol. To
our knowledge, the influence of performing the CAM-ICU on
the total amount of haloperidol used per patient has not been
studied before. It appears plausible that, besides the earlier
detection of delirious patients, also recovery from the delirious
period could be detected earlier with the use of a delirium
assessment tool. As a result, haloperidol treatment would be
stopped earlier. Our data confirm these assumptions. It is also
possible that the early treatment of delirium could result in
shortening of the delirious period, but this assumption needs
further study.
Conclusions
Tailoring our implementation strategy to the needs of the ICU
was successful. The main goals were achieved within a rela-
tively short time. Early recognition of delirium with the CAM-
ICU has become a standard component of daily care by the
nurses in our ICU and contributes to the quality of care. In
addition, early detection of delirium leads to lower dosage and
shorter periods of haloperidol treatment in critically ill patients.
Key messages
• Implementation of the CAM-ICU is feasible and results 
in a higher determination rate of delirium.
• When the CAM-ICU is used, more patients receive 
haloperidol, but in a lower dose and for a shorter period 
of time.Page 6 of 7
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